Highlights
- Mass General Brigham Biobank marks 15 years and 150,000 participants, enhancing research capabilities.
- Collaboration with BROADBAND streamlines data collection for radiation therapy studies.
- Focus on pediatric malignancies to broaden research impact and inclusivity in oncology.
The Mass General Brigham Biobank is celebrating its 15th anniversary, marking a significant milestone with its 150,000th participant. As a leading biobank, it plays a crucial role in facilitating research on common diseases by providing free genomic data and low-cost biosamples linked to electronic health records. This initiative has positioned the biobank as one of the largest of its kind globally, and its extensive participant base is vital for advancing medical research.
With over 250,000 biosamples distributed for nearly 600 unique studies, the Biobank has been instrumental in generating more than 400 peer-reviewed publications. This research spans various disease areas, including cancer, diabetes, and psychiatric disorders, underscoring its importance in the field of personalized medicine.
A notable collaboration has emerged with the BROADBAND (Brigham Radiation Oncology All-Department Biorepository to Accelerate New Discoveries) study, designed to gather clinical data and biospecimens from radiation therapy patients. By leveraging the Biobank’s existing infrastructure, BROADBAND has efficiently consented close to 8,000 participants, integrating research efforts and optimizing resources. This synergy allows researchers to better understand the efficacy of radiation treatments across diverse patient demographics.
Dr. David Kozono, the principal investigator of BROADBAND, emphasizes the value of this partnership in enhancing the precision of radiation therapy. By analyzing the genetic data from the Biobank, the research team can identify optimal treatment strategies tailored to individual patient needs.
Looking to the future, the BROADBAND initiative aims to include pediatric malignancies in its research scope, supported by a recent grant from the National Cancer Institute. This endeavor reflects a commitment to improving inclusivity in cancer research, which is essential for developing effective therapies across all age groups. Through these collaborative efforts, the Mass General Brigham Biobank continues to be a pivotal resource for advancing oncology research and personalized medicine.
About the Author
Biobanking.com delivers valuable news and information on biobanking, biorepositories, cryopreservation, and biosample/biospecimen management, while connects buyers with top vendors globally.
